Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Tubo-ovarian abscess
Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Rupture and sepsis need immediate source control
Shock, confusion, rising lactate, rigid abdomen, diffuse peritonism or sudden deterioration in a patient with a pelvic abscess suggests sepsis, rupture or uncontrolled infection.
Action: Use ABCDE and the sepsis pathway, obtain cultures without delaying treatment, start protocol-led intravenous broad-spectrum antibiotics, call senior gynaecology, anaesthesia and microbiology, and arrange urgent drainage or surgery.
Overview
Recognise tubo-ovarian abscess as severe polymicrobial pelvic infection, start precise inpatient antimicrobial treatment, and escalate promptly to image-guided drainage or surgery when source control is needed.
Tubo-ovarian abscess sits at the severe end of pelvic inflammatory disease. Ascending infection spreads from cervix through endometrium and tubes, causing suppuration, adhesions and a complex inflammatory mass that incorporates ovary, tube and sometimes bowel or peritoneum. Gonorrhoea and chlamydia account for only a minority of UK PID; anaerobes, vaginal flora and other organisms contribute, so treatment must be broad even when an STI test identifies one pathogen.
Presentation varies from gradual bilateral pelvic pain and discharge to acute sepsis. Ask about fever, vomiting, deep dyspareunia, abnormal bleeding, urinary and bowel symptoms, recent instrumentation, intrauterine contraception, previous PID, antibiotics, STI exposure and pregnancy possibility. Obtain a confidential sexual history without implying blame. Examination includes observations, hydration, abdominal tenderness and peritonism; speculum and bimanual examination should be consented and deferred if instability makes immediate resuscitation more important.
Aetiology
01
Ascending polymicrobial infection
Cervical and vaginal organisms ascend through endometrium and tubes, with gonococci, chlamydia, anaerobes and vaginal flora contributing variably.
02
Distorted pelvic anatomy
Prior PID, endometriosis, surgery or inflammatory adhesions can impair drainage and create compartments in which infection localises.
03
Non-gynaecological spread
Appendiceal, diverticular or other bowel infection can involve the adnexa, particularly in atypical, recurrent or postmenopausal presentations.
Pathophysiology
1
Tubal mucosal injury
Ascending organisms inflame tubal epithelium, disrupt ciliary function and generate purulent exudate within an obstructed swollen tube.
2
Inflammatory mass formation
Oedematous tube and ovary adhere to each other and neighbouring structures, walling infection into a complex multiloculated collection.
3
Systemic inflammatory response
Bacterial products and host mediators enter the circulation, causing vasodilation, capillary leak and organ dysfunction when sepsis progresses.
4
Rupture and contamination
Abscess-wall failure releases pus into the peritoneum, converting local disease into diffuse peritonitis and urgent source-control need.
Clinical features and red flags
Severe PID phenotype
Fever, lower abdominal pain, cervical-motion or adnexal tenderness and systemic illness supports ascending infection with possible abscess.
Complex inflammatory mass
A thick-walled multiloculated adnexal collection with debris, hyperaemia and loss of normal tubo-ovarian planes is characteristic but not pathognomonic.
Persistent fever, pain, inflammatory markers or collection after appropriate antibiotics indicates inadequate source control, resistance or an alternative diagnosis.
Atypical-source phenotype
Postmenopausal, recurrent, enteric or right-sided abscess patterns should prompt evaluation for malignancy, appendix, bowel and other non-STI sources.
Red flags requiring action
Hypotension, altered mental state, mottling, oliguria, hypoxia or elevated lactate indicates organ dysfunction and requires immediate sepsis escalation.
Sudden generalised pain, guarding or rigid abdomen in a known abscess raises concern for rupture and emergency operative source control.
Pregnancy with pelvic pain or a mass requires specialist admission because ectopic pregnancy, obstetric infection and antimicrobial safety alter management.
Investigations
01Immediate pregnancy testFirst step
Why
Exclude ectopic pregnancy and identify a context requiring obstetric and antimicrobial modification.
Interpretation and limitations
A positive result with pain or a mass demands specialist early-pregnancy assessment; PID in pregnancy requires admission and tailored parenteral treatment.
02Transvaginal pelvic ultrasound
Why
Identify tubo-ovarian anatomy, collection size and complexity, free fluid and a drainage route.
Interpretation and limitations
A complex inflammatory mass supports abscess, while a negative or indeterminate scan cannot override sepsis or an evolving surgical abdomen.
03STI nucleic-acid testing
Why
Detect gonorrhoea, chlamydia and locally available Mycoplasma genitalium to guide patient and partner treatment.
Interpretation and limitations
A positive test supports ascending infection; negative cervical results do not exclude polymicrobial upper-genital-tract disease.
04Full blood count, CRP and organ profiles
Why
Assess inflammatory burden, anaemia, renal function, hepatic function and antimicrobial safety.
Interpretation and limitations
Trends help judge response but no single inflammatory value proves source control or excludes rupture.
Differential diagnosis
01
Ectopic pregnancy
Pregnancy with pelvic pain, bleeding, free fluid or a complex adnexal lesion needs urgent pregnancy-location assessment despite fever or raised CRP.
02
Ovarian torsion
Abrupt unilateral pain and vomiting with an enlarged ovary may have minimal fever and requires time-critical surgical assessment.
03
Appendiceal or diverticular abscess
Bowel symptoms, gas in a collection or atypical location suggests a gastrointestinal source requiring joint surgical management.
04
Ovarian malignancy
A necrotic tumour can resemble abscess, especially after menopause or when a mass persists despite adequate antimicrobial treatment.
Management
01Sepsis or ruptureResuscitate and obtain urgent source controlFirst stepOrgan dysfunction, shock, diffuse peritonism or sudden deterioration suggests uncontrolled or ruptured abscess.+
1Use ABCDE, send blood cultures and lactate where indicated, start intravenous broad-spectrum antibiotics promptly and provide protocol-led fluid resuscitation.
2Call senior gynaecology, anaesthesia, microbiology and relevant surgical teams, arranging CT only if stable enough and it will change immediate source control.
3Proceed to urgent drainage, laparoscopy or laparotomy according to physiology and anatomy, obtaining pus cultures and controlling contamination.
02Confirmed stable abscessAdmit for parenteral treatmentImaging supports tubo-ovarian abscess without current rupture or organ dysfunction.+
1Review allergy, pregnancy, renal and hepatic function, obtain microbiology samples and start a BASHH-supported inpatient antimicrobial regimen.
Complications
01
Sepsis and rupture
Uncontrolled infection can cause diffuse peritonitis, septic shock, multiorgan failure and death without rapid antibiotics and drainage.
02
Tubal-factor infertility
Inflammation destroys cilia and produces fibrosis and adhesions that obstruct gamete transport and reduce spontaneous conception.
03
Future ectopic pregnancy
Damaged partially patent tubes increase the chance that a future pregnancy implants outside the endometrial cavity.
04
Chronic pelvic pain
Residual adhesions, hydrosalpinx and sensitisation can sustain persistent pain and dyspareunia after microbiological infection has resolved.
05
Organ injury during drainage
Dense inflammatory adherence to bowel, bladder and ureter increases procedural injury risk and may require multidisciplinary surgery.
Monitoring and follow-up
Record temperature, pulse, blood pressure, respiratory status, urine output, pain and abdominal signs frequently during the initial inpatient period.
Trend full blood count, CRP, renal and liver profiles according to severity and the antimicrobial regimen, without treating markers in isolation.
Review response well before 72 hours if physiology worsens; at 72 hours, absent clear improvement requires further investigation and source-control planning.
For gentamicin, follow the selected dosing protocol with measured concentrations and renal surveillance rather than copying a dose without pharmacokinetic review.
Track STI, blood and abscess cultures, partner management and completion of the 14-day course with named clinical ownership.
Arrange follow-up imaging when a residual collection, persistent mass, postmenopausal presentation or diagnostic uncertainty remains.
Special situations
Negative swabs do not exclude abscess
Upper-tract infection can be polymicrobial after cervical organisms disappear, so treatment remains broad despite negative lower-genital-tract tests.
Drainage is diagnostic too
Aspirated material provides microbiology and can reveal an unexpected enteric, resistant or non-infectious process while relieving the collection.
Do not wait out sepsis
The 72-hour review interval is not permission to defer drainage when shock, rupture or clinical deterioration requires immediate source control.
The IUD decision is individual
Evidence for routine immediate removal during PID is limited; balance contraception, response and pregnancy risk with specialist sexual-health advice.
Atypical age broadens causation
A postmenopausal abscess should prompt careful search for gynaecological cancer, diverticular disease and other pelvic sources after stabilisation.
Common pitfalls
01
Treating a tubo-ovarian abscess as mild outpatient PID without admission, parenteral therapy or source-control assessment.
02
Waiting for positive STI tests before starting broad-spectrum antibiotics in a clinically severe infection.
03
Allowing the routine 72-hour review point to delay surgery for rupture, peritonitis or worsening sepsis.
04
Continuing sequential antibiotic courses without re-imaging or draining a persistent collection.
05
Using doxycycline-containing adult regimens unchanged in pregnancy without specialist antimicrobial advice.
06
Discharging after fever settles without culture review, partner care, course completion and a plan for any residual mass.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA
BASHH inpatient regimen
A non-pregnant adult is admitted with a tubo-ovarian abscess and has no relevant drug allergy. Which regimen matches a BASHH inpatient option?
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Pregnancy testing is essential because ectopic pregnancy is a dangerous mimic and antimicrobial choices change. Send vulvovaginal or endocervical nucleic-acid tests for gonorrhoea and chlamydia and test for other infections according to BASHH and local pathways, including HIV and syphilis. A negative lower-tract result does not exclude PID or abscess. Obtain blood cultures before antibiotics in sepsis when this causes no delay, and culture drained material because it may reveal enteric or resistant organisms.
Transvaginal ultrasound can show a thick irregular complex adnexal mass, internal debris, septations, dilated fluid-filled tubes and increased peripheral vascularity. The normal distinction between tube and ovary may disappear. CT of abdomen and pelvis is valuable when appendicitis, diverticulitis, inflammatory bowel disease, urinary infection or broader intra-abdominal sepsis is possible. MRI can solve selected indeterminate problems but should not postpone drainage in a deteriorating patient.
Admit and begin intravenous therapy after allergy, pregnancy, renal and hepatic review. BASHH's ceftriaxone regimen uses 2 g IV daily plus doxycycline 100 mg twice daily, with IV treatment continued until 24 hours after clinical improvement and oral doxycycline 100 mg twice daily plus metronidazole 400 mg twice daily used to complete 14 days. The clindamycin-gentamicin alternative needs weight-based dosing, renal monitoring and gentamicin levels. Local resistance and microbiology advice can modify the regimen.
Antibiotics alone may succeed, but an abscess is a source-control problem as well as an infection. Review temperature, pain, observations, examination and inflammatory markers frequently. BASHH advises review at 72 hours in PID and further investigation or intervention when improvement fails. For a known inpatient abscess, senior review should occur earlier if physiology worsens; do not wait for a fixed time in sepsis or suspected rupture.
Drainage route depends on collection location, stability, pregnancy and local expertise. Ultrasound-guided transvaginal or percutaneous aspiration or catheter drainage can provide culture and source control with less invasiveness. Laparoscopy allows washout, adhesiolysis and drainage but risks injury in distorted inflamed planes. Laparotomy may be necessary for rupture, uncontrolled sepsis, bowel involvement or inability to achieve safe minimal-access control. Preserve ovarian and tubal tissue when clinically safe, but survival and source control take precedence.
After improvement, complete the full antimicrobial course and address transmission and recurrence. Arrange partner notification and treatment through sexual-health pathways, advise avoiding sexual contact until the patient and partners complete treatment and follow-up, and confirm contraception needs. Review at two to four weeks can check clinical recovery, adherence and partner care. Persistent mass, recurrent infection, infertility concerns or postmenopausal disease needs further gynaecological investigation rather than repeated empirical antibiotics.
Key points
A tubo-ovarian abscess is an inflammatory mass involving fallopian tube, ovary and adjacent tissues, most often representing severe ascending pelvic inflammatory disease with polymicrobial aerobic and anaerobic infection.
Symptoms include lower abdominal pain, fever, deep dyspareunia, abnormal discharge or bleeding; examination may show lower abdominal, cervical-motion and adnexal tenderness, but no feature is sufficiently sensitive to exclude disease.
Obtain pregnancy testing, STI nucleic-acid tests including gonorrhoea and chlamydia, HIV and syphilis testing, full blood count, CRP, renal and liver profiles, and cultures when septic; negative cervical tests do not exclude upper-tract infection.
Transvaginal ultrasound usually identifies a thick-walled complex adnexal collection, dilated tube, internal debris and hyperaemia; CT helps when bowel, appendix, urinary disease or wider abdominal sepsis is possible.
A tubo-ovarian abscess warrants hospital care, intravenous broad-spectrum treatment and early senior review; BASHH recommends parenteral therapy for severe disease and abscess.
One BASHH inpatient regimen is ceftriaxone 2 g IV daily plus doxycycline 100 mg twice daily, switching after improvement to oral doxycycline 100 mg twice daily plus metronidazole 400 mg twice daily to complete 14 days.
An alternative is clindamycin 900 mg IV three times daily plus gentamicin with level-guided dosing, followed by clindamycin or doxycycline with metronidazole to complete 14 days.
Drain percutaneously, transvaginally or surgically when rupture, sepsis, diagnostic uncertainty, persistent collection or inadequate clinical response makes antibiotics alone insufficient; ultrasound-guided aspiration is less invasive than laparoscopy in suitable anatomy.
Failure to improve clinically within 72 hours of appropriate treatment should trigger renewed imaging, microbiology review and drainage or surgery assessment.
Postmenopausal presentation, unusual organisms, recurrent abscess or a persistent mass after infection resolves warrants investigation for malignancy, bowel disease or another source.
05
Blood and abscess cultures
Why
Identify bloodstream infection or collection organisms and refine therapy in severe, recurrent or resistant disease.
Interpretation and limitations
Collect blood before antibiotics when feasible without delay and send drained pus for aerobic and anaerobic culture.
06CT abdomen and pelvis
Why
Define collection extent and evaluate bowel, appendix, urinary tract or other intra-abdominal sources when ultrasound is insufficient.
Interpretation and limitations
CT guides multidisciplinary source control but should not postpone surgery in a patient with rupture, peritonitis or worsening shock.
2Record collection dimensions and drainage accessibility, involve senior gynaecology early and provide analgesia, fluids and thrombosis assessment.
3Track clinical improvement closely and switch to oral completion therapy only after sustained response and a secure source-control plan.
03Inadequate responseRe-image and drain rather than repeat blindlyFever, pain, sepsis physiology or inflammatory markers fail to improve with appropriate antibiotics.+
1AlternativeConfirm dose delivery, cultures, antimicrobial susceptibility and alternative diagnoses, with microbiology review of coverage and adherence.
2Repeat targeted imaging to assess enlargement, multiloculation, rupture or a bowel and appendiceal source.
3Arrange image-guided drainage or surgery according to collection access, fertility priorities, instability and the need to exclude malignancy.
04Recovery and preventionComplete treatment and interrupt reinfectionPain, fever and physiology improve after antibiotics with or without drainage.+
1Complete 14 days of the chosen regimen, review drug adverse effects and ensure any drained collection and blood culture results are actioned.
2Arrange sexual-health partner notification and treatment and advise avoiding sexual contact until treatment and follow-up are complete.
3Review within the appropriate interval for clinical resolution, contraception, recurrent symptoms and later fertility or ectopic-pregnancy counselling.
Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
BASHH inpatient broad-spectrum regimen covering common gonococcal, chlamydial, aerobic and anaerobic contributors to severe PID and tubo-ovarian abscess.
Ceftriaxone, doxycycline and metronidazole
Ceftriaxone 2 g intravenously once daily plus doxycycline 100 mg intravenously or orally twice daily; continue parenteral therapy until 24 hours after clinical improvement, then doxycycline 100 mg orally twice daily plus metronidazole 400 mg orally twice daily to complete 14 days total.
Check immediate beta-lactam allergy, pregnancy, liver function and interacting medicines; doxycycline can cause oesophagitis and photosensitivity and is generally avoided in pregnancy, so obtain specialist obstetric and microbiology advice.
Alternative BASHH inpatient regimen providing strong anaerobic and Gram-negative coverage when selected through allergy, microbiology and local antimicrobial review.
Clindamycin and gentamicin alternative
Clindamycin 900 mg intravenously three times daily plus gentamicin 2 mg/kg loading then 1.5 mg/kg three times daily; after improvement use clindamycin 450 mg orally four times daily, or doxycycline 100 mg twice daily plus metronidazole 400 mg twice daily, to complete 14 days.
Use actual protocol weight and monitor gentamicin concentrations and renal function because nephrotoxicity and ototoxicity are exposure related; review pregnancy, neuromuscular disease, diarrhoea and Clostridioides difficile risk.